Clarify drives demonstrable impact for commercial teams

60%

More patients with a rare heart condition were identified by uncovering patients who were most likely mis-diagnosed

3x

More scripts of a rare disease treatment were written by HCPs that Clarify scored as high-opportunity

7k

Patients identified at high risk of non-adherence to infusion therapy by using social determinants of health data

Life sciences analytics, queryable in seconds

Clarify Growth, Pharma analytics software by clarify health

Clarify Growth

Enhance your brand’s launch and in-market performance with our real-world commercial analytics. They extract the micro-level detail you need to compete differently. You can sub-segment patients by any inclusion and exclusion criteria, rank HCP based on therapy-specific factors, and track share versus your competitors at the patient segment level.

Pfizer and Clarify talk data strategies for commercialization

Pfizer and Clarify Health sat down with HLTH to talk about creating data-driven value stories for new therapies. Hear what Bhash Parasuraman, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer and Manisha Gulati, Chief Operating Officer, Clarify Health have to say.

Resources

Case Study

Optimize Drug Uptake at Launch and Track Market Evolution Using Deep, Longitudinal Patient and Physician Insights

For Life Sciences

White Paper

Next-gen applications of SBDoH-decorated data

For Healthcare Providers, Health Plans & Life Sciences

Let’s work together